Paper30133478
Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).
Al Mahtab M and 8 others. PLoS One, 2018. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial). Papers, record 30133478. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30133478
- Disease
- chronic hepatitis B virus infection82 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B Core Antigens | Major topic |
| Hepatitis B Surface Antigens | Major topic |
| Hepatitis B, Chronic | Major topic |
| Adolescent | |
| Adult | |
| Antiviral Agents | |
| Drug Therapy, Combination | |
| Female | |
| Hepatitis B Vaccines | |
| Hepatitis B e Antigens | |
| Hepatitis B virus | |
| Humans | |
| Interferon alpha-2 | |
| Interferon-alpha | |
| Interferons | |
| Male | |
| Middle Aged | |
| Polyethylene Glycols | |
| Recombinant Proteins | |
| Treatment Outcome | |
| Vaccines | |
| Viral Load |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01374308 | NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients | Derived from the trial | Yes |
Source ClinicalTrials.gov
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24555998 | Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN. | Gut | 2015 | https://conductscience.org/library/papers/24555998 | PubMed |
| 2 | 15589316 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Mol Immunol | 2005 | https://conductscience.org/library/papers/15589316 | PubMed |
| 3 | 18596958 | A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. | PLoS One | 2008 | https://conductscience.org/library/papers/18596958 | PubMed |
| 4 | 25645624 | The royal wedding in chronic hepatitis B: The haves and the have-nots for the combination of pegylated interferon and nucleos(t)ide therapy. | Hepatology | 2015 | https://conductscience.org/library/papers/25645624 | PubMed |
| 5 | 10770795 | The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. | J Exp Med | 2000 | https://conductscience.org/library/papers/10770795 | PubMed |
| 6 | 27210427 | Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. | J Hepatol | 2016 | https://conductscience.org/library/papers/27210427 | PubMed |
| 7 | 20834101 | Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection. | Antivir Ther | 2010 | https://conductscience.org/library/papers/20834101 | PubMed |
| 8 | 18031872 | Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. | Vaccine | 2007 | https://conductscience.org/library/papers/18031872 | PubMed |
| 9 | 22762143 | A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy. | J Viral Hepat | 2012 | https://conductscience.org/library/papers/22762143 | PubMed |
| 10 | 15660957 | Immunomodulatory therapy for chronic hepatitis B virus infection. | Fundam Clin Pharmacol | 2005 | https://conductscience.org/library/papers/15660957 | PubMed |
| 11 | 17257877 | Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens. | Int J Infect Dis | 2007 | https://conductscience.org/library/papers/17257877 | PubMed |
| 12 | 26626120 | Novel insights into immunotherapy for hepatitis B patients. | Expert Rev Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/26626120 | PubMed |
| 13 | 20949114 | The Role of Interferon in Hepatitis B Therapy. | Curr Hepat Rep | 2010 | https://conductscience.org/library/papers/20949114 | PubMed |
| 14 | 25132755 | Natural history of chronic hepatitis B: phases in a complex relationship. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25132755 | PubMed |
| 15 | 21682661 | Recent advances in the treatment of chronic hepatitis B. | Expert Opin Pharmacother | 2011 | https://conductscience.org/library/papers/21682661 | PubMed |
| 16 | 9185774 | Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. | Hepatology | 1997 | https://conductscience.org/library/papers/9185774 | PubMed |
| 17 | 19408969 | Management of chronic hepatitis B. | Evid Rep Technol Assess (Full Rep) | 2008 | https://conductscience.org/library/papers/19408969 | PubMed |
| 18 | 26231459 | Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Lancet | 2015 | https://conductscience.org/library/papers/26231459 | PubMed |
| 19 | 19124812 | Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19124812 | PubMed |
| 20 | 26202028 | Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B. | Hepatol Int | 2013 | https://conductscience.org/library/papers/26202028 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42798495 | Preventive and Therapeutic Vaccination for COVID-19 Using NASVAC. | Euroasian J Hepatogastroenterol | 2026 | https://conductscience.org/library/papers/42798495 | PubMed |
| 42797641 | Nucleos(t)ide Analog-Therapeutic Vaccination Switch: A Novel Approach for Safe and Effective Treatment Discontinuation in HBeAg (-) Chronic Hepatitis B Patients. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797641 | PubMed |
| 42233029 | Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42233029 | PubMed |
| 41757140 | The Sustainable Goal of Eliminating Hepatitis B, Functional Cure, and the Prospect of NASVAC: A Review. | Euroasian J Hepatogastroenterol | 2025 | https://conductscience.org/library/papers/41757140 | PubMed |
| 41746052 | EPIclip: A Novel Approach for the Production of Decorated Virus-Like Particles Mediated by High-Affinity Protein Binding Partners. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746052 | PubMed |
| 41295547 | Hepatitis Vaccines: Recent Advances and Challenges. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295547 | PubMed |
| 41149045 | Chronic Hepatitis B: Current Management and Future Directions. | Diseases | 2025 | https://conductscience.org/library/papers/41149045 | PubMed |
| 41014398 | Do the therapeutic vaccines hold hope for the treatment of hepatitis B? | Hepatol Int | 2025 | https://conductscience.org/library/papers/41014398 | PubMed |
| 40677768 | Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: 'Progress toward hepatitis B elimination in Canada'. | Can Liver J | 2024 | https://conductscience.org/library/papers/40677768 | PubMed |
| 40624334 | Identification of low-molecular compounds that inhibit envelope formation of hepatitis B virus. | Sci Rep | 2025 | https://conductscience.org/library/papers/40624334 | PubMed |
| 40528594 | [Research progress on new drugs for the treatment of chronic hepatitis B virus infection]. | Zhonghua Gan Zang Bing Za Zhi | 2025 | https://conductscience.org/library/papers/40528594 | PubMed |
| 40212575 | Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study. | Oman Med J | 2024 | https://conductscience.org/library/papers/40212575 | PubMed |
| 39802853 | HeberNasvac: Development and Application in the Context of Chronic Hepatitis B. | Euroasian J Hepatogastroenterol | 2024 | https://conductscience.org/library/papers/39802853 | PubMed |
| 39717542 | Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39717542 | PubMed |
| 38935536 | Harnessing CD8+ T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/38935536 | PubMed |
| 38222949 | Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac. | Euroasian J Hepatogastroenterol | 2023 | https://conductscience.org/library/papers/38222949 | PubMed |
| 38140265 | HBV Vaccines: Advances and Development. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38140265 | PubMed |
| 37539053 | Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells. | Front Immunol | 2023 | https://conductscience.org/library/papers/37539053 | PubMed |
| 37509583 | Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. | Biomedicines | 2023 | https://conductscience.org/library/papers/37509583 | PubMed |
| 37243066 | Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37243066 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| HBE1 | 3046 | PubTator's text mining | https://conductscience.org/library/genes/3046 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| KRT88P | 85348 | PubTator's text mining | https://conductscience.org/library/genes/85348 | NCBI Gene |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| INTERFERON ALFA-2B | CHEMBL1201558 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201558 | ChEMBL |
| HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN | CHEMBL4297973 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL4297973 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30133478
GET https://conductscience.org/api/papers/v1/30133478/references?page=2